Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment
ABSTRACT Recent reports indicate that the sputum of 80% or more of treatment-naive subjects with tuberculosis recruited in England or South Africa contained more viable Mycobacterium tuberculosis cells detected by limiting dilution (LD) in liquid culture than detected as CFU. Efforts to generate suc...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/512b0576a1e3473490f90c8d7e472437 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:512b0576a1e3473490f90c8d7e472437 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:512b0576a1e3473490f90c8d7e4724372021-11-15T15:52:19ZDifferentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment10.1128/mBio.02192-182150-7511https://doaj.org/article/512b0576a1e3473490f90c8d7e4724372018-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02192-18https://doaj.org/toc/2150-7511ABSTRACT Recent reports indicate that the sputum of 80% or more of treatment-naive subjects with tuberculosis recruited in England or South Africa contained more viable Mycobacterium tuberculosis cells detected by limiting dilution (LD) in liquid culture than detected as CFU. Efforts to generate such differentially detectable (DD) M. tuberculosis populations in vitro have been difficult to reproduce, and the LD assay is prone to artifact. Here, we applied a stringent version of the LD assay to sputum from 33 treatment-naive, HIV-negative Haitian subjects with drug-sensitive tuberculosis (TB) and to a second sputum sample after two weeks of standard treatment with isoniazid, rifampin, pyrazinamide, and ethambutol (HRZE) for 13 of these subjects. Twenty-one percent had statistically defined levels of DD M. tuberculosis in their pretreatment sputum at an average proportional excess over CFU of 3-fold. Sixty-nine percent of those who received HRZE had statistically defined levels of DD M. tuberculosis in their sputum, and of these, the mean proportionate excess over CFU was 7.9-fold. Thus, DD M. tuberculosis is detectable in pretreatment sputum from a significant proportion of subjects in the Western Hemisphere, and certain drugs or drug regimens, while reducing CFU, may at the same time increase the proportional representation of DD M. tuberculosis among the surviving bacilli. Monitoring DD M. tuberculosis may improve our ability to predict the efficacy of efforts to shorten treatment. IMPORTANCE Measurement of the reduction in CFU in sputum of patients with TB up to 2 weeks after the initiation of treatment is the gateway test for a new TB treatment. Reports have suggested that CFU assays fail to detect the majority of viable M. tuberculosis cells in sputum samples from the majority of patients when the number of M. tuberculosis is estimated by limiting dilution (LD). In an effort to avoid potential methodologic confounders, we applied a modified version of the LD assay in a study of a geographically distinct population. We confirmed that differentially detectable (DD) M. tuberculosis is often found before treatment, albeit at lower proportionate levels than in earlier reports. Strikingly, the prevalence and proportionate representation of DD M. tuberculosis increased during standard treatment. Sublethal exposure to certain antibiotics may help generate DD M. tuberculosis cells or enrich their representation among the surviving bacteria, and this may contribute to the need for prolonged treatment with those agents in order to achieve durable cures.Kathrine McAulayKohta SaitoThulasi WarrierKathleen Frances WalshLaurent Daniel MathurinGertrude Royal-MardiMyung Hee LeeOksana OcheretinaJean William PapeDaniel W. FitzgeraldCarl F. NathanAmerican Society for MicrobiologyarticleMycobacterium tuberculosisdifferentially detectable bacteriaearly bactericidal activityrifampinviable but nonculturable bacteriaMicrobiologyQR1-502ENmBio, Vol 9, Iss 6 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Mycobacterium tuberculosis differentially detectable bacteria early bactericidal activity rifampin viable but nonculturable bacteria Microbiology QR1-502 |
| spellingShingle |
Mycobacterium tuberculosis differentially detectable bacteria early bactericidal activity rifampin viable but nonculturable bacteria Microbiology QR1-502 Kathrine McAulay Kohta Saito Thulasi Warrier Kathleen Frances Walsh Laurent Daniel Mathurin Gertrude Royal-Mardi Myung Hee Lee Oksana Ocheretina Jean William Pape Daniel W. Fitzgerald Carl F. Nathan Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| description |
ABSTRACT Recent reports indicate that the sputum of 80% or more of treatment-naive subjects with tuberculosis recruited in England or South Africa contained more viable Mycobacterium tuberculosis cells detected by limiting dilution (LD) in liquid culture than detected as CFU. Efforts to generate such differentially detectable (DD) M. tuberculosis populations in vitro have been difficult to reproduce, and the LD assay is prone to artifact. Here, we applied a stringent version of the LD assay to sputum from 33 treatment-naive, HIV-negative Haitian subjects with drug-sensitive tuberculosis (TB) and to a second sputum sample after two weeks of standard treatment with isoniazid, rifampin, pyrazinamide, and ethambutol (HRZE) for 13 of these subjects. Twenty-one percent had statistically defined levels of DD M. tuberculosis in their pretreatment sputum at an average proportional excess over CFU of 3-fold. Sixty-nine percent of those who received HRZE had statistically defined levels of DD M. tuberculosis in their sputum, and of these, the mean proportionate excess over CFU was 7.9-fold. Thus, DD M. tuberculosis is detectable in pretreatment sputum from a significant proportion of subjects in the Western Hemisphere, and certain drugs or drug regimens, while reducing CFU, may at the same time increase the proportional representation of DD M. tuberculosis among the surviving bacilli. Monitoring DD M. tuberculosis may improve our ability to predict the efficacy of efforts to shorten treatment. IMPORTANCE Measurement of the reduction in CFU in sputum of patients with TB up to 2 weeks after the initiation of treatment is the gateway test for a new TB treatment. Reports have suggested that CFU assays fail to detect the majority of viable M. tuberculosis cells in sputum samples from the majority of patients when the number of M. tuberculosis is estimated by limiting dilution (LD). In an effort to avoid potential methodologic confounders, we applied a modified version of the LD assay in a study of a geographically distinct population. We confirmed that differentially detectable (DD) M. tuberculosis is often found before treatment, albeit at lower proportionate levels than in earlier reports. Strikingly, the prevalence and proportionate representation of DD M. tuberculosis increased during standard treatment. Sublethal exposure to certain antibiotics may help generate DD M. tuberculosis cells or enrich their representation among the surviving bacteria, and this may contribute to the need for prolonged treatment with those agents in order to achieve durable cures. |
| format |
article |
| author |
Kathrine McAulay Kohta Saito Thulasi Warrier Kathleen Frances Walsh Laurent Daniel Mathurin Gertrude Royal-Mardi Myung Hee Lee Oksana Ocheretina Jean William Pape Daniel W. Fitzgerald Carl F. Nathan |
| author_facet |
Kathrine McAulay Kohta Saito Thulasi Warrier Kathleen Frances Walsh Laurent Daniel Mathurin Gertrude Royal-Mardi Myung Hee Lee Oksana Ocheretina Jean William Pape Daniel W. Fitzgerald Carl F. Nathan |
| author_sort |
Kathrine McAulay |
| title |
Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| title_short |
Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| title_full |
Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| title_fullStr |
Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| title_full_unstemmed |
Differentially Detectable <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment |
| title_sort |
differentially detectable <named-content content-type="genus-species">mycobacterium tuberculosis</named-content> cells in sputum from treatment-naive subjects in haiti and their proportionate increase after initiation of treatment |
| publisher |
American Society for Microbiology |
| publishDate |
2018 |
| url |
https://doaj.org/article/512b0576a1e3473490f90c8d7e472437 |
| work_keys_str_mv |
AT kathrinemcaulay differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT kohtasaito differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT thulasiwarrier differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT kathleenfranceswalsh differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT laurentdanielmathurin differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT gertruderoyalmardi differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT myungheelee differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT oksanaocheretina differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT jeanwilliampape differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT danielwfitzgerald differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment AT carlfnathan differentiallydetectablenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentcellsinsputumfromtreatmentnaivesubjectsinhaitiandtheirproportionateincreaseafterinitiationoftreatment |
| _version_ |
1718427274961747968 |